# End-to-End 3-Article Subtopic Synthesis Verification Report

## 1. Domain Classification Audit
- **Falciparum Malaria** -> `disease`
- **Clostridium tetani** -> `microorganism`
- **Amyloidosis** -> `pathology`
- **Amoxicillin** -> `drug_chemical`
- **Brachial plexus** -> `anatomy`
- **Rigor mortis** -> `medicolegal`
- **Primary prevention** -> `public_health`

## 2. Pure-Prose Sanitization Audit (Images, Tables, Captions Stripped)
- **Harrison Principles of Internal Medicine**: Raw `234` words -> Sanitized `194` words (100% tables/images/captions removed)
- **ZIM: Plasmodium falciparum**: Raw `157` words -> Sanitized `148` words (100% tables/images/captions removed)
- **Infectious_Diseases_High_Yield_Notes**: Raw `124` words -> Sanitized `115` words (100% tables/images/captions removed)

## 3. Subtopic Routing Across 3 Articles (4 Subtopic Buckets Created)
### Subtopic: `Causes, Vector & Pathogenesis` (`etiology_transmission`)
- **Canonical Question Anchor**: *What are the causes, etiology, vector, mode of transmission, risk factors, and pathogenesis of Falciparum Malaria?*
- **Primary Source (Harrison Principles of Internal Medicine, p.154)**: `22` words
  > Falciparum malaria is a protozoan parasitic infection caused by Plasmodium falciparum and transmitted via the bite of an infected female Anopheles mosquito.
- **Matched Secondary #1 (ZIM: Plasmodium falciparum, p.1)**: `18` words
  > Transmission occurs through the bite of the female Anopheles mosquito, which introduces motile sporozoites into the human bloodstream.

### Subtopic: `Clinical Features (Signs & Symptoms)` (`clinical_features`)
- **Canonical Question Anchor**: *What are the clinical features, presenting symptoms, physical signs, and classic triad of Falciparum Malaria?*
- **Primary Source (Harrison Principles of Internal Medicine, p.154)**: `42` words
  > Patients present with high irregular fever, chills, diaphoresis, headache, and myalgias following an incubation period of 9 to 14 days. Severe falciparum malaria is defined by parasitemia > 5%, cerebral malaria with symmetric encephalopathy, hypoglycemia, lactic acidosis, and renal impairment (blackwater fever).
- **Matched Secondary #1 (ZIM: Plasmodium falciparum, p.1)**: `29` words
  > Clinical presentation includes paroxysmal fever, splenomegaly, hepatomegaly, and hemolytic anemia. Major life-threatening complications include cerebral malaria (coma, seizures), non-cardiogenic pulmonary edema (ARDS), acute tubular necrosis, and algid malaria (shock).

### Subtopic: `Diagnosis, Staging & Pathology` (`diagnosis_pathology`)
- **Canonical Question Anchor**: *What are the diagnostic criteria, gold standard test, laboratory findings, imaging, gross morphology, and microscopy of Falciparum Malaria?*
- **Primary Source (Harrison Principles of Internal Medicine, p.154)**: `26` words
  > Gold standard diagnosis is microscopic examination of thick and thin peripheral blood smears stained with Giemsa or Wright stain . Rapid diagnostic tests detect HRP-2 antigen.
- **Matched Secondary #1 (Infectious_Diseases_High_Yield_Notes, p.1)**: `28` words
  > Peripheral smear microscopy: Thick smear has highest sensitivity for parasite detection; thin smear is used for species identification. HRP-2 rapid antigen test remains positive for weeks after cure.

### Subtopic: `Treatment & Prevention` (`treatment_prevention`)
- **Canonical Question Anchor**: *What is the first-line treatment, drug of choice, surgical management, and primary prevention or prophylaxis for Falciparum Malaria?*
- **Primary Source (Harrison Principles of Internal Medicine, p.154)**: `31` words
  > Uncomplicated falciparum malaria is treated with oral artemisinin-based combination therapy (ACT) such as artemether-lumefantrine. Intravenous quinine loading dose is 20 mg/kg over 4 hours followed by 10 mg/kg every 8 hours.
- **Matched Secondary #1 (ZIM: Plasmodium falciparum, p.1)**: `39` words
  > The drug of choice for severe falciparum malaria is intravenous artesunate 2.4 mg/kg IV administered at 0, 12, and 24 hours, then once daily. Primary chemoprophylaxis for travelers to endemic regions uses atovaquone-proguanil, doxycycline 100 mg daily, or mefloquine.
- **Matched Secondary #2 (Infectious_Diseases_High_Yield_Notes, p.1)**: `46` words
  > Severe malaria criteria in endemic adults require parasitemia > 10% or severe organ dysfunction. For intravenous quinine therapy in patients who recently received mefloquine, administer a reduced maintenance dose of 10 mg/kg every 12 hours without a loading dose to prevent fatal cardiotoxicity and QT prolongation.

## 4. Full 3-Article Synthesis Execution (`LM Studio Live = False`)
### Subtopic Word Count & Budget Verification
- **Treatment & Prevention**: `3` clinical points, `116` total words (Limit: `<= 1000` words) - **PASS**
- **Causes, Vector & Pathogenesis**: `2` clinical points, `40` total words (Limit: `<= 1000` words) - **PASS**
- **Clinical Features (Signs & Symptoms)**: `2` clinical points, `71` total words (Limit: `<= 1000` words) - **PASS**
- **Diagnosis, Staging & Pathology**: `2` clinical points, `54` total words (Limit: `<= 1000` words) - **PASS**

### Variance / Discrepancy Audit Output
```markdown
- Divergent dosing/threshold for 'mg/kg': Primary [10 mg/kg, 20 mg/kg] vs Secondary [2.4 mg/kg]
```

### Final Rendered Clinical Markdown (`enhanced_explanation`)
```markdown
### Treatment & Prevention
- Uncomplicated falciparum malaria is treated with oral artemisinin-based combination therapy (ACT) such as artemether-lumefantrine. Intravenous quinine loading dose is 20 mg/kg over 4 hours followed by 10 mg/kg every 8 hours. *(Harrison Principles of Internal Medicine, p.154)*
- The drug of choice for severe falciparum malaria is intravenous artesunate 2.4 mg/kg IV administered at 0, 12, and 24 hours, then once daily. Primary chemoprophylaxis for travelers to endemic regions uses atovaquone-proguanil, doxycycline 100 mg daily, or mefloquine. *(ZIM: Plasmodium falciparum, p.1)*
- Severe malaria criteria in endemic adults require parasitemia > 10% or severe organ dysfunction. For intravenous quinine therapy in patients who recently received mefloquine, administer a reduced maintenance dose of 10 mg/kg every 12 hours without a loading dose to prevent fatal cardiotoxicity and QT prolongation. *(Infectious_Diseases_High_Yield_Notes, p.1)*

### Causes, Vector & Pathogenesis
- Falciparum malaria is a protozoan parasitic infection caused by Plasmodium falciparum and transmitted via the bite of an infected female Anopheles mosquito. *(Harrison Principles of Internal Medicine, p.154)*
- Transmission occurs through the bite of the female Anopheles mosquito, which introduces motile sporozoites into the human bloodstream. *(ZIM: Plasmodium falciparum, p.1)*

### Clinical Features (Signs & Symptoms)
- Patients present with high irregular fever, chills, diaphoresis, headache, and myalgias following an incubation period of 9 to 14 days. Severe falciparum malaria is defined by parasitemia > 5%, cerebral malaria with symmetric encephalopathy, hypoglycemia, lactic acidosis, and renal impairment (blackwater fever). *(Harrison Principles of Internal Medicine, p.154)*
- Clinical presentation includes paroxysmal fever, splenomegaly, hepatomegaly, and hemolytic anemia. Major life-threatening complications include cerebral malaria (coma, seizures), non-cardiogenic pulmonary edema (ARDS), acute tubular necrosis, and algid malaria (shock). *(ZIM: Plasmodium falciparum, p.1)*

### Diagnosis, Staging & Pathology
- Gold standard diagnosis is microscopic examination of thick and thin peripheral blood smears stained with Giemsa or Wright stain . Rapid diagnostic tests detect HRP-2 antigen. *(Harrison Principles of Internal Medicine, p.154)*
- Peripheral smear microscopy: Thick smear has highest sensitivity for parasite detection; thin smear is used for species identification. HRP-2 rapid antigen test remains positive for weeks after cure. *(Infectious_Diseases_High_Yield_Notes, p.1)*
```